GSK1940029 (SCD inhibitor 1) (Synonyms: SCD inhibitor 1) |
カタログ番号GC32780 |
GSK1940029(SCD阻害剤1)(SCD阻害剤1)は、特許WO/2009060053A1、化合物例16から抽出されたステアロイルコアデサチュラーゼ(SCD)阻害剤である。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1150701-66-8
Sample solution is provided at 25 µL, 10mM.
GSK1940029 is a stearoyl-coa desaturase (SCD) extracted from patent WO/2009060053 A1, compound example 16.
GSK1940029 is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease[1].
[1]. Anne Marie Jeanne Bouillot, et al. 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors . PCT Int. Appl. (2009), WO 2009060053 A1 20090514.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *